| Financial Year |
March 31 2023 |
| Monetary Funds |
1,352,435,829.67 |
| Held-for-trading Financial Assets |
150,081,369.86 |
| Notes Receivable |
82,396,276.20 |
| Accounts Receivable |
349,235,627.62 |
| Advances to Suppliers |
39,071,009.14 |
| Other Receivables |
27,080,838.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
491,992,763.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,437,296.96 |
| Total Current Assets |
2,493,731,011.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,176,183.51 |
| Investment Properties |
-- |
| Fixed Assetes |
255,514,643.39 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
349,539,290.54 |
| R&D expenses |
-- |
| Goodwill |
271,837,092.68 |
| Long-Term Deferred and Prepaid Expenses |
6,675,619.85 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
996,473,782.56 |
| Total Assets |
3,490,204,794.03 |
| Short-Term Loans |
145,727,956.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,128,080.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,703,905.90 |
| Taxes Payable |
22,839,164.33 |
| Interest Payable |
1,682,745.83 |
| Dividend Payable |
-- |
| Other payables |
2,660,068.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,179,829.28 |
| Other Current Liabilities |
1,872,429.25 |
| Sub-Total of Current Liabilities |
340,650,035.40 |
| Long-term Loans |
-- |
| Bonds Payable |
502,422,901.07 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,742,279.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
573,251,701.20 |
| Total Liabilities |
913,901,736.60 |
| Paid-In Capital(Or Share Stock) |
229,967,404.00 |
| Capital Surplus |
610,686,727.04 |
| Surplus Reserve |
102,694,449.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,305,688,425.27 |
| Minority Stockholder's Interest |
233,515,981.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,342,787,075.80 |
| Owner's Equity（Stockholder's Equity） |
2,576,303,057.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,490,204,794.03 |
